Loading
Investor Information Request
OmniComm Systems, Inc. serves the world’s pharmaceutical, biotechnology, Clinical Research Organizations (CROs), as well as medical device organizations around the globe. Our products and services help maximize the value of our clients' clinical research investments through the use of innovative and progressive technologies.
OmniComm products and services have been used in over 3,000 clinical trials around the world, from trial Phases I through IV, spanning every therapeutic area of clinical research.
To learn more about investing in OmniComm Systems, Inc., please contact our financial team via the link below.